The immunotherapeutic landscape in non–small cell lung cancer and its surgical horizons

Lung cancer continues to be a leading cause of cancer-related death worldwide. Despite tremendous advances in surgical technique, chemotherapy regimens, radiation, and targeted therapies, survival is

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of thoracic and cardiovascular surgery 2020-04, Vol.159 (4), p.1616-1623
Hauptverfasser:	Rhodin, Kristen E., Rucker, A. Justin, Ready, Neal E., D'Amico, Thomas A., Antonia, Scott J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma, Non-Small-Cell Lung - immunology Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - therapy Humans Immunotherapy Lung Neoplasms - immunology Lung Neoplasms - pathology Lung Neoplasms - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Lung cancer continues to be a leading cause of cancer-related death worldwide. Despite tremendous advances in surgical technique, chemotherapy regimens, radiation, and targeted therapies, survival is
ISSN:	0022-5223 1097-685X
DOI:	10.1016/j.jtcvs.2019.08.138